Prostate Cancer Archive

A 2022 study suggests that men who follow active surveillance for low-grade prostate cancer can manage stress and anxiety about their condition by following a high-intensity interval training program.

Active surveillance allows men with low- or intermediate-risk prostate cancer to avoid temporarily the side effects of invasive therapies, but men often feel anxious about their cancer. Emerging evidence suggests there may be a middle path between no treatment and aggressive therapies.

Prostate cancer can progress over long durations, and if a man's tumor has features that predict slow growth, he can opt for active surveillance instead of immediate treatment. But when the time for treatment comes, up to a third of men still decide against it. Now, a new study finds that for some of these men, treatment can be safely delayed.

Scary or misleading claims about things that may cause cancer are so plentiful that it's hard to know which ones to take seriously. A new website developed by experts aims to provide reliable information about whether a particular cancer claim is true.

The FDA has approved a new medication therapy for advanced prostate cancer that is spreading in the body. The new treatment can seek out and destroy tumors that are still too small to be found via conventional medical imaging. Results of a clinical trial showed that this new drug was effective at delaying cancer progression.

Today, most surgeries to remove the prostate gland in men with prostate cancer are performed with robotic assistance, which ostensibly offers quality-of-life advantages. But how does this method compare with traditional open surgery? A recent study provides some clarity.

Many men have questions regarding the testing and screening processes for prostate cancer, such as whether prostate-specific antigen tests are still the standard, when it is time for a biopsy, and what new technologies are available to help with a more accurate diagnosis. Harvard Medical School prostate cancer expert Dr. Marc Garnick provides the answers.